We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+8.7%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$189B
AUM Growth
-$6.65B
Cap. Flow
-$21B
Cap. Flow %
-11.12%
Top 10 Hldgs %
16.9%
Holding
4,784
New
635
Increased
1,494
Reduced
2,137
Closed
388

Sector Composition

Rank Sector Weight
1 Technology 14.66%
2 Healthcare 11.06%
3 Financials 8.17%
4 Consumer Discretionary 8.09%
5 Communication Services 6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRI icon
2051
Carter's
CRI
$1.46B
$4.97M ﹤0.01%
48,650
-4,902
-9% -$499K
ENOV icon
2052
Enovis
ENOV
$1.78B
$4.97M ﹤0.01%
63,547
-10,568
-14% -$809K
WTFC icon
2053
Wintrust Financial
WTFC
$11B
$4.97M ﹤0.01%
65,727
-8,272
-11% -$646K
NUVA
2054
DELISTED
NuVasive, Inc.
NUVA
$4.97M ﹤0.01%
73,308
-2,248
-3% -$153K
KMPR icon
2055
Kemper
KMPR
$1.72B
$4.94M ﹤0.01%
66,905
-9,624
-13% -$742K
FSLR icon
2056
PUT
First Solar
FSLR
$25B
$4.93M ﹤0.01%
54,500
ASAN icon
2057
Asana
ASAN
$2.02B
$4.93M ﹤0.01%
77,450
+46,541
+151% +$1.8M
NBIS
2058
PUT
Nebius Group N.V.
NBIS
$57.3B
$4.91M ﹤0.01%
69,400
-24,800
-26% -$1.63M
SIG icon
2059
Signet Jewelers
SIG
$3.69B
$4.91M ﹤0.01%
64,263
+7,777
+14% +$503K
ADSK icon
2060
CALL
Autodesk
ADSK
$49.6B
$4.9M ﹤0.01%
16,800
+11,300
+205% +$3.22M
INO icon
2061
Inovio Pharmaceuticals
INO
$72M
$4.9M ﹤0.01%
44,062
+8,696
+25% +$835K
SPCE icon
2062
CALL
Virgin Galactic
SPCE
$379M
$4.89M ﹤0.01%
5,205
-5,100
-49% -$2.9M
NTNX icon
2063
CALL
Nutanix
NTNX
$16.6B
$4.88M ﹤0.01%
127,700
+8,600
+7% +$268K
PTR
2064
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
$4.87M ﹤0.01%
+102,671
New +$4.17M
INOV
2065
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
$4.87M ﹤0.01%
142,761
-3,939
-3% -$122K
KREF
2066
KKR Real Estate Finance Trust
KREF
$465M
$4.85M ﹤0.01%
224,828
+8,739
+4% +$183K
CACC icon
2067
Credit Acceptance
CACC
$6.15B
$4.84M ﹤0.01%
10,660
+925
+10% +$379K
ALNY icon
2068
PUT
Alnylam Pharmaceuticals
ALNY
$29.5B
$4.83M ﹤0.01%
28,500
-46,100
-62% -$6.75M
RL icon
2069
PUT
Ralph Lauren
RL
$22.6B
$4.83M ﹤0.01%
41,300
-3,800
-8% -$476K
TNL icon
2070
Travel + Leisure Co
TNL
$4.72B
$4.82M ﹤0.01%
82,154
-11,170
-12% -$708K
ENDP
2071
CALL
DELISTED
Endo International plc
ENDP
$4.82M ﹤0.01%
+1,029,900
New +$5.91M
DUK icon
2072
PUT
Duke Energy
DUK
$96.9B
$4.81M ﹤0.01%
49,000
+31,500
+180% +$3.16M
PAYX icon
2073
PUT
Paychex
PAYX
$41.9B
$4.81M ﹤0.01%
44,800
CRSP icon
2074
CALL
CRISPR Therapeutics
CRSP
$4.88B
$4.79M ﹤0.01%
29,600
-9,700
-25% -$1.18M
CLF icon
2075
CALL
Cleveland-Cliffs
CLF
$7.02B
$4.79M ﹤0.01%
228,700
+28,700
+14% +$565K

Similar funds

Credit Suisse's Q2 2021 Portfolio in Review

As of Q2 2021, Credit Suisse held 4,784 positions worth $189B, down 3.4% from $195B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Credit Suisse withdrew a net $21B in Q2 2021, closing 388 positions and reducing 2,137 holdings. Its most notable exit was INPHI CORPORATION, an estimated $356M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Credit Suisse opened a new position in Recursion Pharmaceuticals worth $52.9M.

  • Credit Suisse's largest Q2 2021 buy was Recursion Pharmaceuticals: 1,449,585 shares worth $52.9M.
  • Credit Suisse added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $826M increase.
  • Credit Suisse's biggest Q2 2021 reduction was Alibaba, cutting an estimated $1.27B.
  • Credit Suisse fully exited INPHI CORPORATION in Q2 2021, selling an estimated $356M.
  • Credit Suisse's ten largest holdings make up 17% of its $189B portfolio in Q2 2021.
  • Credit Suisse opened 635 new positions and closed 388 in Q2 2021.
  • Credit Suisse's portfolio value fell 3.4% quarter-over-quarter to $189B.

Based on Credit Suisse's 13F filing for Q2 2021, filed 16 Aug 2021.